COVID-19 testing is critical to diagnose individuals who may spread the diseases as well as to create strategies that may aid to prevent further spread of SARS-CoV-2. There are two types of COVID-19 tests — those that are designed to detect whether a patient has an acute infection (diagnostic tests), and those intended to detect antibodies (surveillance tests).
In this webinar, you can learn more about Beckman Coulter’s High-Quality Laboratory Tests that are intended to deliver accurate and reliable results that clinicians can trust.
Learning objectives
- Clinical utility of serology vs antigen testing
- Barriers to mass testing
- Low-touch testing
- Confidence in results
- Impact of mutations to current testing options